A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.
Clinical trial NCT01160003 · COMPLETED
Trial details
- NCT number
- NCT01160003
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-29
- Primary completion
- 2010-11-05
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.